Efficacy and safety of ciclesonide in the treatment of 24,037 asthmatic patients in routine medical care.

Author: BethkeThomas D, HeringThomas, LewinThomas, SanderPeter, VogelmeierClaus F

Paper Details 
Original Abstract of the Article :
BACKGROUND: The efficacy and safety profile of ciclesonide (CIC) in the treatment of asthma was evaluated in a large patient population in a real-life setting in Germany. METHODS: 24,037 patients with persistent mild/moderate bronchial asthma were enrolled into three observational studies with iden...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.rmed.2010.09.016

データ提供:米国国立医学図書館(NLM)

Ciclesonide: A Reliable Oasis in the Desert of Asthma

Asthma, like a sandstorm, can disrupt our lives, leaving us breathless and struggling to breathe. This study explores the efficacy and safety profile of ciclesonide, a medication used to treat asthma, in a large patient population. The researchers sought to assess the real-world effectiveness of this medication in managing asthma symptoms.

Ciclesonide's Effectiveness in Asthma: A Breath of Fresh Air

The study reveals that ciclesonide demonstrates significant efficacy in improving lung function and reducing asthma symptoms. Patients treated with ciclesonide experienced significant improvements in their forced expiratory volume in one second (FEV1), peak expiratory flow (PEF), and nitric oxide (NO) levels. This translates into fewer asthma episodes, reduced reliance on rescue medication, and an overall improvement in quality of life for patients with asthma.

Managing Asthma: Navigating the Desert of Symptoms

This research provides reassuring evidence for the effectiveness and safety of ciclesonide in managing asthma. The study's findings suggest that ciclesonide can be a valuable tool for patients with asthma, offering a reliable oasis in the desert of symptoms. Just as we learn to adapt to the harsh conditions of the desert, we must continue to explore and refine our treatment strategies for asthma to ensure the well-being of patients.

Dr.Camel's Conclusion

This research, like a camel navigating the vast desert of asthma, highlights the efficacy and safety of ciclesonide as a treatment option. The study's findings demonstrate that ciclesonide can significantly improve lung function and reduce asthma symptoms, providing a beacon of hope for patients struggling with this chronic respiratory condition. Just as we learn to appreciate the resilience of life in the desert, we must continue to seek innovative solutions to improve the lives of those affected by asthma.

Date :
  1. Date Completed 2011-05-05
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

21067906

DOI: Digital Object Identifier

10.1016/j.rmed.2010.09.016

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.